|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0171 | ED148568 | General Research Use | No | Female | White | 74 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0360 | ED149667 | General Research Use | No | Female | White | 82 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0395 | ED148706 | General Research Use | No | Female | White | 70 | 6 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0562 | ED148400 | General Research Use | No | Female | White | 61 | 6 - AREDS AMD Severity Scale Step 6 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0862 | ED148470 | General Research Use | No | Male | White | 71 | 6 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0956 | ED149371 | General Research Use | No | Female | Black or African American | 57 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0974 | ED149965 | General Research Use | No | Male | White | 58 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1056 | ED149583 | General Research Use | No | Male | Native Hawaiian or other Pacific | 79 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1066 | ED148882 | General Research Use | No | Male | White | 60 | 6 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_1087 | ED148828 | General Research Use | No | Male | White | 78 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1263 | ED149510 | General Research Use | No | Female | White | 68 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2088 | ED149308 | General Research Use | No | Female | White | 58 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2323 | ED148511 | General Research Use | No | Female | Black or African American | 79 | 6 - AREDS AMD Severity Scale Step 6 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_2417 | ED149709 | General Research Use | No | Male | White | 69 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2425 | ED148805 | General Research Use | No | Female | White | 80 | 6 - AREDS AMD Severity Scale Step 5 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2628 | ED149058 | General Research Use | No | Male | White | 83 | 6 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_2654 | ED148037 | General Research Use | No | Female | White | 67 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3360 | ED149519 | General Research Use | No | Female | White | 74 | 6 - AREDS AMD Severity Scale Step 6 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_3588 | ED149380 | General Research Use | No | Male | White | 70 | 6 - AREDS AMD Severity Scale Step 6 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_3774 | ED149393 | General Research Use | No | Male | White | 73 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |